Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Isaac's syndrome is an immune-mediated peripheral motor neuron disorder characterized by continuous muscle fiber activity at rest resulting in muscle stiffness, cramps, myokymia, and pseudomyotonia.
Features include common findings: Excessive sweating (hyperhidrosis), Weight loss, EEG abnormality, and Fasciculations and others; and sometimes findings: Distal sensory impairment. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 6 | Fasciculations, Muscle spasm, Muscle stiffness |
Biomarker and diagnostic research for Isaac syndrome has been reported in the published literature.
Phenotype severity distribution: 11 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Isaac syndrome.
59 publications have been identified in PubMed for Isaac syndrome. Research spans Case Report / Case Series (40%), Review / Meta-Analysis (17%), and Clinical Trial Publication (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 21 | 40% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Isaac syndrome
Skin
1 |
Excessive sweating (hyperhidrosis) |
Growth and development | 1 | Weight loss |
Brain and nerves | 1 | Fasciculations |
9 |
17% |
Clinical study results | 7 | 13% |
Disease patterns and progression | 7 | 13% |
Testing and diagnosis research | 3 | 6% |
Laboratory research | 3 | 6% |
New treatment approaches | 2 | 4% |
Other research | 1 | 2% |
Cakar MM (2026). [PMID: 41348524](https://pubmed.ncbi.nlm.nih.gov/41348524/). *J Clin Neurophysiol*. [Review / Meta-Analysis]
Hassan F (2026). [PMID: 41956272](https://pubmed.ncbi.nlm.nih.gov/41956272/). *Autoimmun Rev*. [Review / Meta-Analysis]
Sabas RR (2026). [PMID: 41636862](https://pubmed.ncbi.nlm.nih.gov/41636862/). *Eur J Orthop Surg Traumatol*. [Case Report / Case Series]
Li Y (2026). [PMID: 41869344](https://pubmed.ncbi.nlm.nih.gov/41869344/). *Front Immunol*. [Case Report / Case Series]
Nirschl CJ (2026). [PMID: 41685778](https://pubmed.ncbi.nlm.nih.gov/41685778/). *Cancer Immunol Res*. [Gene Therapy / Novel Therapeutics]
Snow ALB (2026). [PMID: 41632350](https://pubmed.ncbi.nlm.nih.gov/41632350/). *Res Child Adolesc Psychopathol*. [Clinical Trial Publication]
Sugimoto T (2026). [PMID: 42125544](https://pubmed.ncbi.nlm.nih.gov/42125544/). *Clin Neurophysiol Pract*. [Case Report / Case Series]
Isaacs JD (2025). [PMID: 40023669](https://pubmed.ncbi.nlm.nih.gov/40023669/). *Semin Arthritis Rheum*. [Review / Meta-Analysis]
Isaacs D (2025). [PMID: 40529843](https://pubmed.ncbi.nlm.nih.gov/40529843/). *Fed Pract*. [Case Report / Case Series]
Parry RH (2025). [PMID: 41081472](https://pubmed.ncbi.nlm.nih.gov/41081472/). *J Med Virol*. [Clinical Trial Publication]